Evidence map›Paper›PMID 39813299›Full record

ArticlePloS one2025

Dynamics of SARS-CoV-2 infection over two epidemic waves in Manaus, Brazil: A serological study of seven thousand blood donors.

Neal Alexander, Christopher Dye, Michael P Busch, Lewis Buss, Carlos A Prete, Oliver J Brady, Paul Mee, Claudia M M Abrahim, Myuki A E Crispim, Allyson G da Costa and 5 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Neal AlexanderDepartment of Infectious Disease Epidemiology, MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-6707-7876
Christopher DyeDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Michael P BuschVitalant Research Institute, San Francisco, CA, United States of America.
Lewis BussFaculdade de Medicina da Universidade de São Paulo, Instituto de Medicina Tropical, São Paulo, Brazil.
Carlos A PreteDepartment of Electronic Systems Engineering, Universidade de São Paulo, São Paulo, Brazil.
Oliver J BradyDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Paul MeeDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Claudia M M AbrahimFundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HemoAM), Manaus, Brazil.
Myuki A E CrispimFundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HemoAM), Manaus, Brazil.
Allyson G da CostaFundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HemoAM), Manaus, Brazil.ORCID 0000-0002-7312-6822
Tassila SalomonFaculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0002-8123-3118
Philippe MayaudFaculty of Infectious and Tropical Diseases, Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-5730-947X
Márcio K OikawaCenter of Mathematics, Computing and Cognition, Universidade Federal do ABC, Santo André, Brazil.
Nuno R FariaFaculdade de Medicina da Universidade de São Paulo, Instituto de Medicina Tropical, São Paulo, Brazil.
Ester C SabinoFaculdade de Medicina da Universidade de São Paulo, Instituto de Medicina Tropical, São Paulo, Brazil.ORCID 0000-0003-2623-5126

Funding

NHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007IWellcome Trust
6 · The paper itself

Abstract

backgroundMost longitudinal studies of COVID-19 incidence have used unlinked samples. The city of Manaus, Brazil, has a blood donation program which allows sample linkage, and was struck by two large COVID-19 epidemic waves between mid-2020 and early 2021.

methodsWe estimated the changing force of infection, i.e. incidence in susceptible individuals. Seroconversion was inferred by a mixture model for serial values from the Abbott Architect SARS-CoV-2 nucleocapsid (N) IgG assay. We estimated the number of suspected COVID-19 hospitalizations arising from each infection over calendar time.

resultsWhole blood donations between April 2020 and March 2021 were included from 6734 people, 2747 with two or more donations. The inferred criterion for seroconversion, and thus an incident infection, was a 6.07 fold increase in N IgG reactivity. The overall force of infection was 1.19 per person year (95% confidence interval 1.14-1.24) during the two main waves. The estimated number of suspected hospitalizations per infection, was approximately 4.1 times higher in the second wave than in the first.

conclusionsSerial values from this assay can be used to infer seroconversion over time, and in Manaus show a higher number of suspected COVID-19 hospitalizations per infection in the second wave relative to the first.

Indexed as

Blood DonorsCOVID-19SARS-CoV-2AdultAntibodies, ViralBrazilEpidemicsFemaleHospitalizationHumansImmunoglobulin GIncidenceLongitudinal StudiesMaleMiddle AgedSeroconversionAntibodies, ViralImmunoglobulin G

Identifiers

PMID39813299
PMCPMC11734911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.